-
1
-
-
85009030716
-
"Limiter le risque de cancer de l'endomètre: Quelle séquence progestative?
-
Prescrire Rédaction
-
Prescrire Rédaction "Limiter le risque de cancer de l'endomètre: quelle séquence progestative? Rev Prescr 1999; 19 (198): 568.
-
(1999)
Rev. Prescr.
, vol.19
, Issue.198
, pp. 568
-
-
-
2
-
-
85009031656
-
"Livial° - Tibolone - Scientific information"
-
(no dates)
-
Organon "Livial° - tibolone - Scientific information" (no dates): 72 pages.
-
-
-
Organon, A.1
-
3
-
-
85009034151
-
"Tibolone"
-
32nd ed, The Pharmceutical Press, London
-
"Tibolone". In: "Martindale The Complete Drug Reference" 32nd ed, The Pharmceutical Press, London 1999: 1466-1467.
-
(1999)
"Martindale The Complete Drug Reference"
, pp. 1466-1467
-
-
-
4
-
-
85009032486
-
"Norethynodrel"
-
32nd ed, The Pharmaceutical Press, London
-
"Norethynodrel". In: "Matindale The Complete Drug Reference" 32nd ed, The Pharmaceutical Press, London 1999: 1453.
-
(1999)
"Matindale The Complete Drug Reference"
, pp. 1453
-
-
-
5
-
-
0032984538
-
"Livial: A review of clinical studies"
-
Moore RA "Livial: a review of clinical studies" Br J Obstet Gynaecol 1999; 106 (suppl. 19): 1-12.
-
(1999)
Br. J. Obstet. Gynaecol.
, vol.106
, Issue.SUPPL. 19
, pp. 1-12
-
-
Moore, R.A.1
-
6
-
-
85009029846
-
"Tibolone: Dose-response analysis of effects on climacteric symptoms"
-
(Abstr, FC801.6)
-
Johannes E et al: "Tibolone: dose-response analysis of effects on climacteric symptoms" Acta Obstet Gynaecol Scand 1997; 76 (Abstr, FC801.6): 13.
-
(1997)
Acta Obstet. Gynaecol. Scand.
, vol.76
, pp. 13
-
-
Johannes, E.1
-
7
-
-
0020469415
-
"Placebo-controlled crossover study of effects of Org OD 14 in menopausal women"
-
Kicovic PM et al: "Placebo-controlled crossover study of effects of Org OD 14 in menopausal women" Reproduccion 1982; 6: 81-91.
-
(1982)
Reproduccion
, vol.6
, pp. 81-91
-
-
Kicovic, P.M.1
-
8
-
-
0020562144
-
"Efficacy and safety of Org OD 14 in the treatment of climacteric compliants"
-
Trévoux R et al: "Efficacy and safety of Org OD 14 in the treatment of climacteric compliants" Maturitas 1983; 5: 89-96.
-
(1983)
Maturitas
, vol.5
, pp. 89-96
-
-
Trévoux, R.1
-
9
-
-
0021051713
-
"Double-blind cross-over study with Org OD 14 and placebo in post-menopausal patients"
-
Nevinny-Stickel L " Double-blind cross-over study with Org OD 14 and placebo in post-menopausal patients" Arch Gynecol 1983; 234: 27-31.
-
(1983)
Arch. Gynecol.
, vol.234
, pp. 27-31
-
-
Nevinny-Stickel, L.1
-
10
-
-
0023915494
-
"Treatment of climacteric complaints with Org OD 14: A comparative study with oestradiol valerate and placebo"
-
Crona N et al "Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo" Maturatas 1988; 9: 303-308.
-
(1988)
Maturitas
, vol.9
, pp. 303-308
-
-
Crona, N.1
-
11
-
-
0023083159
-
"Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women"
-
Bendek-Jaszmann LJ "Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women: Maturitas 1987; (suppl. 1): 25-33.
-
(1987)
Maturitas
, Issue.SUPPL. 1
, pp. 25-33
-
-
Bendek-Jaszmann, L.J.1
-
12
-
-
0031687747
-
"A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms"
-
Hammar M et al: "A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms" Br J Obstet Gynaecol 1998; 105: 904-911.
-
(1998)
Br. J. Obstet. Gynaecol.
, vol.105
, pp. 904-911
-
-
Hammar, M.1
-
13
-
-
0031041737
-
"Effect on sexual life - A comparison between tibolone and a continuous estadiol-norethisterone acetate regimen"
-
Nathorst-Böös J and Hammar M "Effect on sexual life - A comparison between tibolone and a continuous estadiol-norethisterone acetate regimen" Maturitas 1997; 26: 15-20.
-
(1997)
Maturitas
, vol.26
, pp. 15-20
-
-
Nathorst-Böös, J.1
Hammar, M.2
-
14
-
-
0028200333
-
"The incidence of vaginal bleeding with tibolone treatment"
-
Rymer J et al "The incidence of vaginal bleeding with tibolone treatment" Br J Obstet Gynaecol 1994; 101: 53-56.
-
(1994)
Br. J. Obstet. Gynaecol.
, vol.101
, pp. 53-56
-
-
Rymer, J.1
-
15
-
-
1642618312
-
"Impact on uterine bleeding and endometrial thickness: Tibolone comparated with continuous combined estradiol and norethisterone acetate replacement therapy"
-
Doren M et al "Impact on uterine bleeding and endometrial thickness: tibolone comparated with continuous combined estradiol and norethisterone acetate replacement therapy" Menopause 1999; 6 (4): 299-306.
-
(1999)
Menopause
, vol.6
, Issue.4
, pp. 299-306
-
-
Doren, M.1
-
16
-
-
85009029845
-
"Résumé des caractéristiques de produit - Livial 2,5 mg, comprimé"
-
French agency for health product safety 19 May
-
French agency for health product safety "Résumé des caractéristiques de produit - Livial 2,5 mg, comprimé" 19 May 2000: 8 pages.
-
(2000)
, pp. 8
-
-
-
17
-
-
85009029216
-
"Ménopause, hormones et risque de cancer de sein"
-
Prescrire Rédaction
-
Prescrire Rédaction "Ménopause, hormones et risque de cancer de sein" Rev Prescr 2001; 21 (215): 214-215.
-
(2001)
Rev. Prescr.
, vol.21
, Issue.215
, pp. 214-215
-
-
-
18
-
-
85009030194
-
"Traitement hormonal de la ménopause et risque cardiovasculaire"
-
Prescrire Rédaction
-
Prescrire Rédaction "Traitement hormonal de la ménopause et risque cardiovasculaire" Rev Prescr 1999; 19 (191): 57-58.
-
(1999)
Rev. Prescr.
, vol.19
, Issue.191
, pp. 57-58
-
-
-
19
-
-
0028342455
-
"Endometrial hyperplasia and adenocarcinoma during tibolone (Livial°) therapy"
-
von Dadelzsen P et al. "Endometrial hyperplasia and adenocarcinoma during tibolone (Livial°) therapy" Br J Obstet Gynaecol 1994; 101: 158-161.
-
(1994)
Br. J. Obstet. Gynaecol.
, vol.101
, pp. 158-161
-
-
von Dadelzsen, P.1
-
20
-
-
0029972912
-
"Cause of vaginal bleeding in postmenopausal women taking tibolone"
-
Ginsburg J and Prevelic GM "Cause of vaginal bleeding in postmenopausal women taking tibolone" Maturitas 1996; 24: 107-110.
-
(1996)
Maturitas
, vol.24
, pp. 107-110
-
-
Ginsburg, J.1
Prevelic, G.M.2
-
21
-
-
0025764730
-
"Org OD 14 and the endometrium"
-
Genazzani AR et al. "Org OD 14 and the endometrium" Maturitas 1991; 13: 243-251.
-
(1991)
Maturitas
, vol.13
, pp. 243-251
-
-
Genazzani, A.R.1
-
22
-
-
0028962244
-
"A comparative study of two hormone replacement therapy regimens on safety and efficacy variables"
-
Siseles NO et al "A comparative study of two hormone replacement therapy regimens on safety and efficacy variables" Maturitas 1995; 21: 201-210.
-
(1995)
Maturitas
, vol.21
, pp. 201-210
-
-
Siseles, N.O.1
-
23
-
-
0343924650
-
"Comparison of transvaginal ultasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users"
-
Hänggi W et al "Comparison of transvaginal ultasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users" Maturitas 1997; 27: 133-143.
-
(1997)
Maturitas
, vol.27
, pp. 133-143
-
-
Hänggi, W.1
-
24
-
-
0031042523
-
"Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low dose estrogen or tibolone treatment: A comparison"
-
Botsis D et al "Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low dose estrogen or tibolone treatment: a comparison" Maturitas 1997; 26: 57-62.
-
(1997)
Maturitas
, vol.26
, pp. 57-62
-
-
Botsis, D.1
-
25
-
-
0031011064
-
"Long term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein (a): A randomised study"
-
Hänggi W et al "Long term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein (a): a randomised study" Br J Obstet Gynaecol 1997; 104: 708-717.
-
(1997)
Br. J. Obstet. Gynaecol.
, vol.104
, pp. 708-717
-
-
Hänggi, W.1
-
26
-
-
0029964603
-
"A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin"
-
Milner MH et al "A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin" Obstet Gynaecol 1996; 87 (4): 593-599.
-
(1996)
Obstet. Gynaecol.
, vol.87
, Issue.4
, pp. 593-599
-
-
Milner, M.H.1
-
27
-
-
0021798902
-
"The effect of the synthetic steroid ORG OD14 on fibinolysis and blood lipids in postmenopausal women"
-
Walker ID et al "The effect of the synthetic steroid ORG OD14 on fibinolysis and blood lipids in postmenopausal women" Thromb Haemost 1985; 53 (3): 303-305.
-
(1985)
Thromb. Haemost.
, vol.53
, Issue.3
, pp. 303-305
-
-
Walker, I.D.1
-
28
-
-
0025904288
-
"Non-linear incease in vertebral density induced by a synthetic steiod (ORG OD 14) in women with established osteoporosis"
-
Geusens P et al "Non-linear incease in vertebral density induced by a synthetic steiod (ORG OD 14) in women with established osteoporosis" Maturitas 1991; 13: 155-162.
-
(1991)
Maturitas
, vol.13
, pp. 155-162
-
-
Geusens, P.1
-
29
-
-
0031706247
-
"A randomized study of tibolone on bone mineral density on osteoporotic postmenopausal women with previous fractures"
-
Studd J et al "A randomized study of tibolone on bone mineral density on osteoporotic postmenopausal women with previous fractures" Obstet Gynaecol 1998; 92 (4 Part 1): 574-579.
-
(1998)
Obstet. Gynaecol.
, vol.92
, Issue.4 PART 1
, pp. 574-579
-
-
Studd, J.1
-
30
-
-
0018874858
-
"Prospective double-blind trial of synthetic steriod (Org OD 14) for preventing postmenopausal osteoporosis"
-
Lindsay R et al "Prospective double-blind trial of synthetic steriod (Org OD 14) for preventing postmenopausal osteoporosis" BMJ 1980; 280: 1207-1209.
-
(1980)
BMJ
, vol.280
, pp. 1207-1209
-
-
Lindsay, R.1
-
31
-
-
0029974818
-
"Tibolone: Prevention of bone loss in late postmenopausal women"
-
Bjarnason NH et al "Tibolone: prevention of bone loss in late postmenopausal women" J Clin Endocrinol Metab 1996; 81 (7): 2419-2422.
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, Issue.7
, pp. 2419-2422
-
-
Bjarnason, N.H.1
-
32
-
-
0012953649
-
"Effects of two doses of tibolone in trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study"
-
Berning B et al "Effects of two doses of tibolone in trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study" Bone 1996; 19 (4): 395-399.
-
(1996)
Bone
, vol.19
, Issue.4
, pp. 395-399
-
-
Berning, B.1
-
33
-
-
0031081215
-
"The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women"
-
Bjarnason NH et al "The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women" Bone 1997; 20 (2): 151-155.
-
(1997)
Bone
, vol.20
, Issue.2
, pp. 151-155
-
-
Bjarnason, N.H.1
-
34
-
-
0033012178
-
"Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with tibolone"
-
Berning B et al "Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with tibolone" Maturitas 1999; 31: 151-159.
-
(1999)
Maturitas
, vol.31
, pp. 151-159
-
-
Berning, B.1
-
35
-
-
0032854719
-
"Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures"
-
Pavlov PW et al "Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures" Gynecol Endocrinol 1999; 13: 230-237.
-
(1999)
Gynecol. Endocrinol.
, vol.13
, pp. 230-237
-
-
Pavlov, P.W.1
|